|

Cytomegalovirus Specific T-Lymphocytes Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Jessie L. Alexander1

Indications

  • Adenovirus1
  • Epstein-Barr Virus Infections1
  • Cytomegalovirus Infections1
  • Cancer1

Palo Alto, California1 trial

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Jessie Alexander

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.